JMP Securities Starts Crinetics (CRNX) at Market Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- S&P 500 futures steady after midterm rally; Nasdaq lags on chip weakness
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CRNX Hot Sheet
Price: $84.95 --0%
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 30 | New: 5
Rating Summary:
7 Buy, 12 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 16 | Down: 30 | New: 5
Join SI Premium – FREE
JMP Securities analyst Jonathan Wolleben initiates coverage on Crinetics (NASDAQ: CRNX) with a Market Outperform rating and a price target of $43.00.
For an analyst ratings summary and ratings history on Crinetics click here. For more ratings news on Crinetics click here.
Shares of Crinetics closed at $23.90 yesterday.
You May Also Be Interested In
- Citi initiates ATI Inc. coverage with Buy rating, $229 target
- H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
- CLSA Starts Busy Ming Group (1768:HK) at Outperform (2)
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
